Detalles de la búsqueda
1.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910263
2.
Curability of patients with lymph node metastases from extremity soft-tissue sarcoma.
Cancer
; 126(23): 5098-5108, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32910462
3.
Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.
Oncologist
; 24(4): e146-e148, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30728278
4.
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era.
Oncologist
; 24(7): e518-e525, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833487
5.
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
Int J Cancer
; 142(1): 57-65, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28891048
6.
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors.
Invest New Drugs
; 33(1): 169-76, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25318436
7.
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 33(5): 1100-7, 2015 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26334219
8.
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin.
Invest New Drugs
; 32(6): 1269-77, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25213162
9.
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).
Invest New Drugs
; 32(2): 243-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23645447
10.
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient.
Nat Commun
; 15(1): 1094, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321065
11.
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.
Cancer Treat Rev
; 110: 102455, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031697
12.
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer.
Clin Colorectal Cancer
; 20(4): 334-341, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417144
13.
Molecular targeted therapies in all histologies of head and neck cancers: an update.
Curr Opin Oncol
; 22(3): 212-20, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20173639
14.
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).
J Immunother Cancer
; 7(1): 72, 2019 03 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30867072
15.
Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck.
Cancer Treat Rev
; 54: 43-57, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28192747
16.
Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs.
Clin Cancer Res
; 23(15): 4020-4026, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28377482
17.
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Clin Cancer Res
; 23(6): 1552-1563, 2017 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27649553
18.
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Genome Med
; 8(1): 109, 2016 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27782854
19.
Efficiency of new dose escalation designs in dose-finding phase I trials of molecularly targeted agents.
PLoS One
; 7(12): e51039, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23251419
20.
Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.
Br J Ophthalmol
; 95(11): 1483-9, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21183517